SCHEMBL6568524

SCHEMBL6568524

Cc1ccc(NC(=O)Nc2ccc(Oc3ccccc3)cc2)c(O)c1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR2 P25025 1/20 0.77
CA12 O43570 5/20 0.58
CA1 P00915 5/20 0.58
CA2 P00918 5/20 0.58
CA9 Q16790 5/20 0.58
KMT2A Q03164 5/20 0.57
MEN1 O00255 4/20 0.57
MAPT P10636 4/20 0.57
LMNA P02545 1/20 0.57
NPSR1 Q6W5P4 1/20 0.57
SMN1; SMN2 Q16637 3/20 0.56
NPC1 O15118 2/20 0.56
RAB9A P51151 2/20 0.56
ALDH1A1 P00352 1/20 0.53
PNLIP P16233 1/20 0.53
MAPK1 P28482 2/20 0.52
TP53 P04637 1/20 0.52
GAA P10253 1/20 0.52
HPGD P15428 1/20 0.51
GFER P55789 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5605320 0.87 CXCR2 (1.00) CXCR2KMT2AMEN1MAPTSMN1; SMN2
SCHEMBL4342321 0.86 CA12 (0.60) CXCR2CA12CA1CA2CA9
SCHEMBL6667825 0.85 CA12 (0.59) CXCR2CA12CA1CA2CA9
SCHEMBL12994776 0.84 HPGD (0.65) CA12CA1CA2CA9KMT2A
SCHEMBL30744003 0.84 RAF1 (0.58) CXCR2CA12CA1CA2CA9
SCHEMBL21295340 0.84 RAF1 (0.58) CXCR2CA12CA1CA2CA9
SCHEMBL13224739 0.83 MAPK1 (0.59) CXCR2CA12CA1CA2CA9
SCHEMBL10192075 0.81 KMT2A (0.71) CA12CA1CA2CA9KMT2A
SCHEMBL6568644 0.81 EPHX2 (0.64) CXCR2KMT2AMEN1MAPTNPSR1
SCHEMBL5594982 0.80 CXCR2 (0.79) CXCR2CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1402887-A1 New compounds for the inhibition of undesired cell proliferation and use thereof Jerini AG (DE) 2004-03-31 EP claimed
EP-1402888-A1 The use of substituted carbocyclic compounds as rotamases inhibitors Jerini AG (DE) 2004-03-31 EP claimed